sonnet biotherapeutics stock predictions

The company develops fully. For the readers interested in the stock health of Sonnet BioTherapeutics Holdings Inc.

Sonnet Biotherapeutics Holdings Stock Forecast Up To 3 107 Usd Sonn Stock Price Prediction Long Term Short Term Share Revenue Prognosis With Smart Technical Analysis

SONN stock forecast Our latest prediction for Sonnet BioTherapeutics Holdings Incs stock price was made on the June 9 2021 when the stock price was at 153.

. The Score for SONN is 30 which is 40 below its. For Sonnet BioTherapeutics Holdings stock forecast for 2022 2 predictions are offered for each month of 2022 with. Our proprietary F H AB Fully Human Albumin Binding technology.

As of 2022 October 19 Wednesday current price of SONN stock is 1290 and our data indicates that the asset. In the short term 2weeks. In the TopGraphs chart you can see if NasdaqCMSONN is undervalued.

That Sonnet Biotherapeutics Holdingss share price could reach 200 by Aug 16 2023. When the transactions were called off in the. Stock Forex Fund CryptoCurrency Commodity and Real Estate Markets.

The company develops fully. If the price is below the blue. Sonnet BioTherapeutics Holdings Inc an oncology-focused biotechnology company develops platform for biologic medicines of single or bispecific action.

Expected Surprise Prediction looks to. Get the latest Sonnet BioTherapeutics Holdings Inc SONN detailed stock quotes stock data Real-Time ECN charts stats and more. At Sonnet BioTherapeutics we are taking the fight directly to cancer.

SONN stock forecast Our latest prediction for Sonnet BioTherapeutics Holdings Incs stock price was made on the June 9 2021 when the stock price was at 153. The current Sonnet BioTherapeutics Holdings SONN share price is 114. The average Sonnet Biotherapeutics Holdings stock price.

What analysts think SONN stock price will be. For Sonnet BioTherapeutics Holdings the 5 year risk analysis shows 0 out of 0 areas green. Is Sonnet BioTherapeutics Holdings Stock Undervalued.

Powering a New Wave of Immune Therapeutics. It is currently valued at 021. Based on 1 Wall Street analysts offering 12 month price targets for Sonnet BioTherapeutics Holdings in the last 3 months.

According to the issued ratings of 3 analysts in the last year the consensus rating for Sonnet BioTherapeutics stock is Buy based on the current 3 buy ratings for SONN. 130 rows About the Sonnet BioTherapeutics Holdings Inc. The average price target is 2200 with a high forecast of 2200.

Sonnet BioTherapeutics Holdings Inc an oncology-focused biotechnology company develops platform for biologic medicines of single or bispecific action. On average Wall Street analysts predict. Sonnet BioTherapeutics Price Targets.

From AI system total return is 245147 from 4062 forecasts. While ratings are subjective and will change the latest Sonnet BioTherapeutics SONN rating was a maintained with a price target of 200 to 2200. The current price Sonnet.

Sonnet Biotherapeutics Stock Nasdaq Sonn Analyst Ratings Price Targets Predictions Benzinga